Adaptive Biotechnologies ...
7.01
0.94 (15.49%)
At close: Jan 15, 2025, 1:40 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -225.25M -200.37M -207.30M -146.23M -68.61M -46.45M -42.83M
Depreciation & Amortization 22.23M 20.92M 13.95M 8.47M 7.79M 6.00M 5.80M
Stock-Based Compensation 62.91M 55.48M 43.25M 24.76M 13.12M 11.15M 7.01M
Other Working Capital -44.20M -56.83M -49.48M -43.66M 266.41M -1.32M 1.49M
Other Non-Cash Items 29.97M 11.57M 6.95M 3.34M 43.00K 5.00K 6.00K
Deferred Income Tax n/a n/a 7.23M 773.00K -1.88M -1.24M 637.00K
Change in Working Capital -46.18M -71.55M -56.82M -40.80M 254.93M -1.72M -5.47M
Operating Cash Flow -156.32M -183.94M -192.73M -149.68M 205.40M -32.26M -34.86M
Capital Expenditures -10.70M -16.35M -61.75M -18.80M -11.20M -6.32M -2.51M
Acquisitions n/a -19.25M -181.21M 98.24M 470.50M 19.00K 85.00K
Purchase of Investments -429.56M -278.78M -316.54M -694.97M -884.22M -146.50M -125.18M
Sales Maturities Of Investments 569.90M 298.03M 559.50M 596.72M 413.72M 153.54M 163.91M
Other Investing Acitivies -1 19.25M 181.21M -98.24M -470.50M 19.00K 122.00K
Investing Cash Flow 129.65M 2.90M 181.21M -117.04M -481.70M 736.00K 36.43M
Debt Repayment n/a 124.38M n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 2.25M 7.89M 27.15M 21.43M -934.00K 1.25M 50.03M
Financial Cash Flow 2.25M 132.26M 27.15M 293.59M 319.92M 1.25M 50.03M
Net Cash Flow -24.43M -48.77M 15.63M 26.86M 43.62M -30.27M 51.61M
Free Cash Flow -167.02M -200.29M -254.47M -168.49M 194.20M -38.58M -37.36M